CDKN2A and gastric cancer: Wu et al. reported that overall mutations in cuproptosis genes, changes in PDHB copy number, methylation of CDKN2A, alternative splicing, and APA alterations all affect the prognosis of gastric cancer patients (Wu et al., 2025).